Research Podium—Will You Use My Data? Dialogue Between Award-Winning Researchers & Formulary Decision-Makers

ACPE UAN #: 0233-0000-17-035-H04-P 

Release Date:  March 29, 2017

Expiration Date:  March 29, 2020

Activity Type:    Knowledge-based

Contact Hours:  1.25

Activity Fee:  Member:  $15        Non-Member: $30

Target Audience: Pharmacists who practice in managed care settings.

Activity Overview

Question: How often do researchers interact directly with the managed care decision-makers using the very evidence, they generate to inform policies?

Answer: Not often enough.

In this session, authors of the top-rated posters presented at AMCP Annual Meeting 2017 will present a detailed description of their research projects, and explain how their ­ findings can advance the practice of managed care pharmacy. A panel of managed care decision-makers will share their impressions and reactions, as well as ask probing questions of the authors. The ensuing discussion and interaction between payers and researchers is something you won’t want to miss!

Featured research includes:

  • Does consumer-purchasing data improve medication adherence predictions for the CMS Star categories?
  • Effect of adalimumab initiation at a specialty pharmacy on adherence, persistence, and cost outcomes across autoimmune diseases
  • Applying pharmacoeconomic modeling to formulary decision-making: the case of trabectedin

Learning Objectives:  

At the completion of this activity, participants should be able to:

1. Identify adherence predictors in the three Medicare Star ratings drug categories with and without consumer purchasing data and assess the added value of consumer purchasing data.

2. Discuss the relationship between initiation of adalimumab at specialty pharmacies vs retail pharmacies and outcomes (adherence, persistence, and medical costs) in patients with an indicated autoimmune disease: rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.

3. Discuss how to determine the cost-effectiveness of trabectedin vs. dacarbazine for metastatic soft tissue sarcoma from an institutional perspective using internal cost and outcomes data, and how to apply the results to guide formulary decision-making.

Schedule of Educational Activity

This activity consists of an audio recording, pre-test assessment questions (not required to pass or continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation. 

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at the AMCP Annual Meeting 2017. 

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account. 

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities.  It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.


Karen L. Rascati | PhD, RPh | Professor | University of Texas at Austin | Austin, Texas

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-17-035-H04-P 1.25 Contact Hours March 29, 2017 - March 29, 2020